Some studies suggest that CD11b+ TIMs contribute to a poor prognosis in solid cancers, including gastric cancer, and are associated with recurrence after chemoradiotherapy in head and neck cancer [20,24]. This evidence concerns the gene ITGAM and gastric cancer.